AB-MDMSBA

The following information was compiled in June 2025 and is subject to change as new research is conducted and as new information becomes available:

Description: AB-MDMSBA is a synthetic cannabinoid. AB-MDMSBA was first identified in the United States in September 2024 and since has been reported in Canada, New Zealand, and Australia.^1,2,3 AB-MDMSBA was identified by our laboratory in January 2025 and confirmed after acquiring standard reference material.

Sample Source: NMS Labs — Forensic Drug Chemistry (Willow Grove, PA)

Sample Appearance: Brown powder

Pharmacology: No information is available for the activity and potency of AB-MDMSBA.

Toxicology: AB-MDMSBA has not been detected in toxicology cases to date at the CFSRE.

Drug Materials: AB-MDMSBA has been detected in one drug material to date at the CFSRE.

Demographics / Geographics: The drug material originated from Indiana. AB-MDMSBA was found alone, without the presence of other drugs or substances.

Legal Status: AB-MDMSBA is not currently scheduled in the United States.

Class:

Cannabinoid

Appearance:

Brown powder

Formula:

C15H23N3O4S

MW:

341.4

[M+]:

341

[M+H]+:

342.1482

IUPAC:

N-(1-carbamoyl-2-methyl-propyl)-3-(dimethylsulfamoyl)-4-methyl-benzamide

Report Date:

June 20, 2025